Author

Thomas Bauer

Medical University of ViennaORCID 0000-0002-2076-7140Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Iros BarozziiD· 1 shared Johannes Tuechler· 1 shared Karoline StrobliD· 1 shared Lena Artner-GentiD· 1 shared Maria SibiliaiD· 1 shared Marina GladkovaiD· 1 shared Matthias FarlikiD· 1 shared Regina JiniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Iros BarozziORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

JAK1/2 Inhibition Restores Tissue Integrity by Rewiring Type 1/2 Immunity Toward Targetable IL-17 Responses

Regina Jin, Karoline Strobl, Lena Artner-Gent, Johannes Tuechler, Marina Gladkova, Ulrike Mann, Matthias Farlik, Iros Barozzi, Maria Sibilia, Thomas Bauer

This study shows JAK1/2 inhibition reduces pathogenic immune responses and restores tissue integrity in chronic skin inflammation by shifting immunity toward IL-17 responses.

bioRxiv · Nov 2, 2026 · PreprintImmunology